News

The company is planning to commence the construction work from October 2010 and is expected to start operations in the fiscal 2012. In the new plant, the company

In the GFT505-209-4 and GFT505-109-6 studies, GFT505 showed insulin-sensitising effects in non-diabetic subjects. An international expert panel chaired by Bart Staels, president of the Scientific Advisory Board, encouraged

Emergent BioSolutions’ rPA anthrax vaccine candidate is a purified recombinant protective antigen protein formulated with an alum adjuvant and is designed to induce antibodies that neutralise anthrax toxins.

Patients with COPD using the new Onbrez Breezhaler were also able to reduce their use of rescue medication compared to those using salmeterol, a widely prescribed drug in

Elder Pharmaceuticals already owns 21.1% stake in NeutraHealth. NeutraHealth, which has three group companies – Biocare, Brunel Healthcare and Totally Nourish, focuses on vitamins, minerals and supplements sector

Ulipristal acetate, a new oral emergency contraceptive designed and developed by HRA Pharma, has received approval from the European Commission and the Food and Drug Administration in May

Chi-Med said that the product is produced in Switzerland under an exclusive supply agreement with an independent supplier and has completed the China importation and certification process with

In the study it was observed that the maximal tolerated dose of Inecalcitol is 4mg per day and the response rate to combination treatment reached 85% based on

The Elixir DESyne BD stent combines a low drug dose (5µg/mm stent length) of internally developed macrocyclic lactone Novolimus, a metabolite of sirolimus and a low polymer load